Delivery Order SPE2DR25D3109-SPE2DR26FT2EP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units), with an ultimate completion date of August 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.52 for ORGOVYX 120 mg tablets (30-unit package) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count unit dose packaging) on October 29, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The contract is performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4.38K delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for ORGOVYX 120 mg tablets (30-count units) with performance in Conshohocken, Pennsylvania and completion by November 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-unit package) on October 22, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on June 4, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) under a firm fixed-price contract valued at $1,385.52, with an ultimate completion date of October 8, 2025. This non-set-aside award reflects competitive procurement through open competition and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a firm fixed price arrangement. The contract, awarded on August 27, 2025, is classified as a non-set-aside competitive award with an ultimate completion date of September 18, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30 units per package. This is a firm fixed price delivery order with no set-aside designation, issued on August 28, 2025, with an ultimate completion date of September 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is...
- SPE2DR25D3109Indefinite Delivery Contract
- SPE2DR25D3109-SPE2DR26FT2EPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,380.39 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a firm fixed price contract structure. This is a non-set-aside competitive award with an ultimate completion date of December 10, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The place of performance is listed as the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The contract enables AmerisourceBergen to supply a broad range of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. ORGOVYX, a specialty pharmaceutical product, exemplifies the company's role in delivering brand-name medications across multiple therapeutic domains to federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 11/18/25 |